switching from liraglutide to semaglutide Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies liraglutide to semaglutide dose conversion

In this metabolomic profiling study, 13 long-chain acylcarnitines were analyzed which included 6 saturated (C14, C16, C18, C14OH, C16OH, and C18OH), 5 monounsaturated (C14:1, C16:1, C18:1, C16:1OH, and C18:1OH), and 2 polyunsaturated (C14:2 and C18:2) acylcarnitines

Tan M, et al

These medications reduce hyperglycemia (Hb1Ac reduction of 0.8 1.4%) through the inhibition of glucose reabsorption in the proximal convoluted tubule of the kidney and the resulting increase in glycosuria ( In light of this evidence, these therapies have opened a new paradigm not only for the management of altered glucose metabolism in T2D but also in consideration of their pleiotropic effects ( Emerging data indicate that the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis may play a role in either mediating the metabolic and neuroendocrine effect of these drugs or responding to the profound body modifications fostered by GLP-1RAs and SGLT-2is

Jacobus N

Material exclusivamente para investigacin